Valencell’s foundational patent portfolio in biometric sensors enables advanced biometric wearable and hearable devices
RALEIGH, N.C. – July 20, 2016 – Valencell, the leading innovator in the wearable and hearable biometric sensor field, today announced a non-exclusive patent license agreement with Samsung Electronics Co., Ltd. Under this patent license agreement, Valencell has licensed hearable patents owned by Valencell to Samsung for use in its hearable devices.
“Valencell is continuing to invent the future in biometric sensor technology and market leaders like Samsung Electronics recognize the value of Valencell’s foundational inventions in hearables,” said Dr. Steven LeBoeuf, President and Co-founder of Valencell. “We’re pleased to work with Samsung Electronics to provide a patent license for our inventions that are critical for accurate heart rate monitoring in hearables.”
Valencell has a highly cited patent portfolio in optical biometric sensor technology in the wearables and hearables industry, which includes 35 patents granted and more than 70 additional patents pending.
Valencell licenses its biometric sensor technology through product licensing or patent licensing, depending on the customer and product requirements. While product licensing provides access to Valencell’s patent-protected technology products, patent licensing provides access to Valencell’s inventions without access to Valencell’s technology products and support.
Valencell’s PerformTek® sensor systems provide accurate, robust and flexible technology, powering more biometric hearables and wearables on the market than any other company. The technology gives hearable devices the ability to continuously and accurately measure blood flow signals even during extreme physical activity or when the optical signals are weak. These signals can be translated into biometric data, including continuous heart rate, VO2 and VO2 max, resting heart rate, heart rate response, heart rate recovery, continuous energy expenditure (calorie burn), cardiac efficiency and heart rate variability assessments.
The accuracy of Valencell’s PerformTek technology has been independently validated by numerous research institutions, including Duke University, NC State University, and the American College of Sports Medicine.
Valencell develops performance biometric sensor technology and provides this patent-protected technology to consumer electronics manufacturers, mobile device and accessory makers, sports and fitness brands and gaming companies for integration into their products. Valencell’s PerformTek® biometric sensor technology employs active signal characterization, the process of segmenting raw signal data from biometric sensors into biological, motion, and environmental signals and noise. Valencell’s inventions are currently found in wrist-, arm-, and ear-worn wearables and hearables. Valencell has invested years into the research and development of its PerformTek sensor technology, protected by dozens of granted patents and independently validated by the Duke Center for Living, North Carolina State University, the Human Performance Laboratory and a fellow of the American College of Sports Medicine. For more information, visit www.valencell.wpengine.com.